Buys | $83,812 | 2 | 100 |
Sells | $0 | 0 | 0 |
SEKHRI PAUL J | Pres, CEO and Exec Chairperson | 2 | $83,812 | 0 | $0 | $83,812 |
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetrant phosphodiesterase type 4 (PDE4) inhibitor that addresses inflammatory diseases and psoriasis. It is also involved in the clinical development of other programs, including TTP273, an oral small molecule …
Over the last 12 months, insiders at vTv Therapeutics Inc. have bought $83,812 and sold $0 worth of vTv Therapeutics Inc. stock.
On average, over the past 5 years, insiders at vTv Therapeutics Inc. have bought $1.45M and sold $100,050 worth of stock each year.
Highest buying activity among insiders over the last 12 months: SEKHRI PAUL J (Pres, CEO and Exec Chairperson) — $83,812.
The last purchase of 1,844 shares for transaction amount of $31,269 was made by SEKHRI PAUL J (Pres, CEO and Exec Chairperson) on 2024‑11‑18.
2024-11-18 | SEKHRI PAUL J | Pres, CEO and Exec Chairperson | 1,844 0.058% | $16.96 | $31,269 | -8.58% | ||
2024-11-15 | SEKHRI PAUL J | Pres, CEO and Exec Chairperson | 3,156 0.1377% | $16.65 | $52,543 | -11.15% | ||
2022-11-29 | FRY JOHN A | director | 40,461 0.0852% | $0.83 | $33,773 | -12.01% | ||
2022-11-28 | FRY JOHN A | director | 20,539 0.0431% | $0.83 | $16,969 | -11.38% | ||
2021-12-20 | Sale | PERELMAN RONALD O | director | 87,000 0.154% | $1.15 | $100,050 | -26.54% | |
2021-02-26 | Nelson Rich S. | director | 60,000 0.1142% | $2.86 | $171,600 | -31.58% | ||
2021-02-26 | KOZLOV HERSH | director | 10,000 0.0182% | $2.74 | $27,400 | -31.58% | ||
2020-12-17 | PERELMAN RONALD O | director | 625,000 0.9225% | $1.60 | $1M | -2.36% | ||
2020-12-10 | PERELMAN RONALD O | director | 625,000 0.893% | $1.60 | $1M | -4.79% | ||
2020-11-24 | PERELMAN RONALD O | director | 625,000 1.0514% | $1.60 | $1M | +13.44% | ||
2020-05-15 | KOZLOV HERSH | director | 10,000 0.022% | $3.00 | $30,000 | -22.48% | ||
2020-05-12 | PERELMAN RONALD O | director | 625,000 0.8555% | $1.60 | $1M | -8.98% | ||
2020-02-25 | PERELMAN RONALD O | director | 1.25M 1.438% | $1.60 | $2M | -33.44% | ||
2020-01-28 | PERELMAN RONALD O | director | 1.25M 2.1109% | $1.60 | $2M | -2.29% | ||
2020-01-07 | PERELMAN RONALD O | director | 1.25M 2.5998% | $1.60 | $2M | +20.34% | ||
2019-12-18 | PERELMAN RONALD O | director | 1.37M 4.3437% | $1.46 | $2M | +40.13% | ||
2019-11-26 | PERELMAN RONALD O | director | 1.37M 4.4914% | $1.46 | $2M | +42.86% | ||
2019-11-12 | PERELMAN RONALD O | director | 1.37M 4.3437% | $1.46 | $2M | +38.16% | ||
2019-10-24 | PERELMAN RONALD O | director | 1.37M 4.2053% | $1.46 | $2M | +33.76% | ||
2019-09-26 | PERELMAN RONALD O | director | 1.37M 4.3232% | $1.46 | $2M | +45.83% |
SEKHRI PAUL J | Pres, CEO and Exec Chairperson | 5000 0.1914% | $104,950.00 | 2 | 0 | |
PERELMAN RONALD O | director | 36519212 1397.993% | $766.54M | 61 | 1 | +17.2% |
SAVAS PAUL G | director | 91781 3.5135% | $1.93M | 16 | 0 | +66.67% |
FRY JOHN A | director | 61000 2.3351% | $1.28M | 2 | 0 | <0.0001% |
Nelson Rich S. | director | 50000 1.9141% | $1.05M | 1 | 0 | <0.0001% |
$81,638,324 | 48 | 7.58% | $59.66M | |
vTv Therapeutics Inc. (VTVT) | $77,062,892 | 41 | 13.96% | $54.83M |
$6,787,959 | 35 | 49.84% | $61.13M | |
$459,011,221 | 33 | 33.04% | $58.46M | |
$2,239,226 | 28 | 3.41% | $58.08M |
Increased Positions | 6 | +33.33% | 10,192 | +1.88% |
Decreased Positions | 3 | -16.67% | 467 | -0.09% |
New Positions | <1 | New | 1,803 | New |
Sold Out Positions | 3 | Sold Out | 467 | Sold Out |
Total Postitions | 21 | +16.67% | 552,049 | +1.79% |
Samsara Biocapital, Llc | $3,071.00 | 6.89% | 206,784 | 0 | 0% | 2024-12-31 |
Fmr Llc | $2,646.00 | 5.94% | 178,200 | 0 | 0% | 2024-12-31 |
Baker Bros. Advisors Lp | $1,445.00 | 3.24% | 97,314 | 0 | 0% | 2024-12-31 |
Vanguard Group Inc | $617.00 | 1.39% | 41,558 | 0 | 0% | 2024-12-31 |
Geode Capital Management, Llc | $173.00 | 0.39% | 11,634 | +1,327 | +12.88% | 2024-12-31 |
Ubs Group Ag | $112.00 | 0.25% | 7,512 | +6,646 | +767.44% | 2024-12-31 |
Blackrock, Inc. | $71.00 | 0.16% | 4,773 | +23 | +0.48% | 2024-12-31 |
Jpmorgan Chase & Co | $27.00 | 0.06% | 1,803 | +1,803 | New | 2024-12-31 |
Morgan Stanley | $17.00 | 0.04% | 1,146 | +306 | +36.43% | 2024-12-31 |
Planning Capital Management Corp | $9.00 | 0.02% | 625 | 0 | 0% | 2024-09-30 |